{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:40:14Z","timestamp":1758552014096,"version":"3.44.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1245\/s10434-025-17730-x","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T09:38:55Z","timestamp":1750671535000},"page":"7459-7460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ASO Author Reflections: Reasonable Doubt: The Case for Somatostatin Analogs in Pancreas Surgery Remains Unsettled"],"prefix":"10.1245","volume":"32","author":[{"given":"Kristin E.","family":"Goodsell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan G.","family":"Sham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"17730_CR1","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1056\/NEJMoa1313688","volume":"370","author":"PJ Allen","year":"2014","unstructured":"Allen PJ, Gonen M, Brennan MF, et al. Pasireotide for postoperative pancreatic fistula. N Engl J Med. 2014;370:2014\u201322.","journal-title":"N Engl J Med."},{"key":"17730_CR2","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.hpb.2022.07.011","volume":"24","author":"VG Pillarisetty","year":"2022","unstructured":"Pillarisetty VG, Abbasi A, Park JO, Sham JG. A phase II trial of lanreotide for the prevention of postoperative pancreatic fistula. HPB Oxford. 2022;24:2029\u201334.","journal-title":"HPB Oxford."},{"key":"17730_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.hpb.2024.06.002","volume":"26","author":"SSB Chauhan","year":"2024","unstructured":"Chauhan SSB, Vierra B, Park JO, Pillarisetty VG, Davidson GH, Sham JG. Prophylactic somatostatin analogs for postoperative pancreatic fistulas: a cross-sectional survey of AHPBA surgeons. HPB Oxford. 2024;26:1229\u201336.","journal-title":"HPB Oxford."},{"key":"17730_CR4","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.pan.2020.10.043","volume":"20","author":"S Schorn","year":"2020","unstructured":"Schorn S, Vogel T, Demir IE, et al. Do somatostatin-analogues have the same impact on postoperative morbidity and pancreatic fistula in patients after pancreaticoduodenectomy and distal pancreatectomy? A systematic review with meta-analysis of randomized-controlled trials. Pancreatology. 2020;20:1770\u20138.","journal-title":"Pancreatology."},{"key":"17730_CR5","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17660-8","author":"KE Goodsell","year":"2025","unstructured":"Goodsell KE, Chauhan SSB, Pillarisetty VG, Sham JG. Somatostatin analogs for preventing postoperative pancreatic fistula: past evidence reveals new opportunities. Ann Surg Oncol. 2025. https:\/\/doi.org\/10.1245\/s10434-025-17660-8.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17730-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17730-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17730-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:04:26Z","timestamp":1758549866000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17730-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17730"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17730-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Jonathan G. Sham is Study Chair of S2408, a NCTN-based multicenter randomized trial of lanreotide for the prevention of postoperative pancreatic fistula. This study was sponsored by SWOG, and Dr. Sham received no compensation from SWOG or Cipla pharmaceuticals, which provide drug for the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}